Welcome to our dedicated page for Mirion Technologies news (Ticker: MIR), a resource for investors and traders seeking the latest updates and insights on Mirion Technologies stock.
Mirion Technologies, Inc. reports company developments in radiation detection, measurement, analysis and monitoring solutions for nuclear, medical, defense and research markets. Updates commonly cover financial results, orders, guidance, investor presentations and leadership appointments across the Nuclear & Safety and Medical groups.
Mirion's recurring business themes include nuclear power customers, critical radiation safety applications, R&D labs, nuclear facilities and healthcare uses such as Nuclear Medicine, Radiation Therapy QA, Occupational Dosimetry and Diagnostic Imaging. News also reflects the completed Paragon Energy Solutions acquisition, which added engineered nuclear-power offerings and is being integrated into the Nuclear & Safety group.
Mirion Technologies, Inc. (NYSE: MIR) has completed the acquisition of Computerized Imaging Reference Systems, Inc. (CIRS) for approximately $54 million. CIRS specializes in medical imaging and radiation therapy phantoms, crucial for calibrating diagnostic equipment, measuring radiation doses, and ensuring quality assurance in medical settings. This strategic move is expected to enhance Mirion's Medical segment and improve patient outcomes. However, risks exist regarding integration challenges and anticipated benefits may not fully materialize.
Mirion Technologies (NYSE: MIR) reported a 26% increase in GAAP revenues for Q3 2021, totaling $144.3 million, up from $114.6 million in Q3 2020. However, net loss rose 15.8% to ($46.7) million. Adjusted revenues climbed 29% to $148 million, with Adjusted EBITDA at $30.9 million, a 28% increase. The Medical segment saw a significant revenue increase of 155%. Organic growth was a slight (0.1%) compared to 8.5% in the prior year. Mirion completed its business combination with GS Acquisition Holdings Corp II on October 20, 2021, enhancing liquidity to approximately $230 million.
Mirion Technologies (NYSE:MIR) has announced a definitive agreement to acquire Computerized Imaging Reference Systems, Inc. (CIRS) for approximately $54 million. CIRS, based in Norfolk, Virginia, specializes in developing medical imaging and radiation therapy phantoms, projecting Adjusted Revenue of $16 million and Adjusted EBITDA of $5 million for 2022. The acquisition is expected to enhance Mirion's medical segment and improve margins through operational synergies, making it accretive to adjusted EBITDA margins after integration costs. The transaction is slated to close in Q4 2021.
Mirion Technologies (NYSE: MIR) will announce its financial results for the quarter ending September 30, 2021, on November 12, 2021, prior to market opening. A conference call will follow at 8:00 am ET to discuss the results. Participants can join by dialing 1-877-407-9208 (U.S.) or 1-201-493-6784 (international). A replay will be available until November 26, 2021, accessible at 1-844-512-2921 (U.S.) or 1-412-317-6671 (international). More details are available on Mirion's website.
Mirion Technologies, Inc. (NYSE:MIR) has acquired CHP Dosimetry, a U.S.-based dosimetry services distributor, effective November 1, 2021. CHP Dosimetry, founded in 2004 and located in Clinton, TN, generated $1.2 million in revenue in 2020. This acquisition allows Mirion to serve existing CHP customers directly and leverage CHP's distribution channels for its dosimetry solutions, including the Instadose® platform, improving service efficiency and customer reach.
Mirion Technologies (NYSE: MIR) has commenced trading on the New York Stock Exchange following its successful business combination with GS Acquisition Holdings Corp II. The company's Class A common stock and warrants are now trading under the symbols 'MIR' and 'MIRW'. With a fiscal year 2021 revenue of $612 million, reflecting a growth of 27.9% year-over-year, Mirion aims to expand its product offerings in industrial technology and medical sectors. CEO Thomas Logan anticipates continued growth and welcomes Larry Kingsley as Chairman to lead strategic initiatives.